Clinical site monitoring IDIQ

Ended Indefinite Delivery Contract Awarded Last action

Contract number
HHSF223201710031I
Awardee
Awarding agency
Task orders
29 $434,107 obligated

Award facts

Opportunity
Combined order value
  • $434,107 Current, with exercised options
  • $441,224 Potential, with all options
Last date to order 100% complete
IDV ceiling 43% used
$1,000,000.00
Maximum order
$1,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Competed under SAP · 5 offers Simplified Acquisition
Pricing
Labor Hours
Legislative mandates

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Clinical site monitoring in human subjects for an for an extramural study to evaluate the ability of dermal open flow… 75F40122F19029 Food and Drug Administration $9,354
Clinical site monitoring in human subjects for an extramural study to assess dermal pharmacokinetic (PK) and systemic… 75F40122F19028 Food and Drug Administration $9,003
Clinical site monitoring in human subjects, iowa city, IA 75F40121F19022 Food and Drug Administration $5,354
Clinical site monitoring in human subjects, imperial college london, london, united kingdom 75F40121F19024 Food and Drug Administration $0
Clinical site monitoring for FDA-funded human subject research studies ucsf, SAN francisco CA 75F40121F19021 Food and Drug Administration $1,392
Clinical site monitoring in human subjects, university of south australia, adelaide, australia 75F40121F19027 Food and Drug Administration $10,806
Clinical site monitoring in human subjects, joanneum research, graz, austria 75F40121F19025 Food and Drug Administration $9,065
Clinical site monitoring for FDA-funded human subject research studies, university of michigan (UMI), ANN arbor MI 75F40121F19023 Food and Drug Administration $3,282
Clinical site monitoring in human subjects, university of queensland, brisbane, australia 75F40121F19026 Food and Drug Administration $19,926
Clinical site monitoring for FDA-funded human subject research studies, LOS angeles, irvine, and SAN diego, CA… 75F40120F19020 Food and Drug Administration $24,827
Clinical site monitoring in human subjects, ST louis, MO 75F40120F19019 Food and Drug Administration $54,542
Clinical site monitoring in human subjects, ST louis, MO 75F40120F19018 Food and Drug Administration $14,160
Clinical site monitoring in human subjects, overland park kansas 75F40120F19017 Food and Drug Administration $13,366
Clinical site monitoring in human subjects, columbia, MO. (opioid study) 75F40119F19016 Food and Drug Administration $64,633
Clinical site monitoring in human subjects, baltimore, MD. (riva study) 75F40119F19014 Food and Drug Administration $7,053
Clinical site monitoring in human subjects, baltimore, MD. (diclofenac study) 75F40119F19013 Food and Drug Administration $6,472
Clinical site monitoring in human subjects, baltimore, MD. (metro study) 75F40119F19015 Food and Drug Administration $6,598
Clinical site monitoring in human subjects, baltimore, MD (diclofenac study) 75F40119F19012 Food and Drug Administration $353
Clinical site monitoring in human subjects, university of california: LOS angeles, irvine and davis (CA) 75F40119F19010 Food and Drug Administration $22,264
Clinical site monitoring in human subjects, pittsburgh, PA 75F40119F19011 Food and Drug Administration $9,196
Clinical site monitoring in human subjects, salt lake city UT 75F40119F19009 Food and Drug Administration $7,659
Clinical site monitoring in human subjects, gainesville, FL. 75F40119F01008 Food and Drug Administration $19,859
Clinical site monitoring in human subjects, iowa city, IA 75F40119F01007 Food and Drug Administration $60
Clinical site monitoring in human subjects, boston MA and LAS vegas, NV 75F40119F01006 Food and Drug Administration $180
Clinical site monitoring in human subjects HHSF22301002T Food and Drug Administration $12,866
Clinical site monitoring in human subjects HHSF22301004T Food and Drug Administration $26,929
To #3, gainesville FL. Investigate the pharmacokinetics (PK) of two generic steroid-based nasal spray products in… HHSF22301003T Food and Drug Administration $22,556
To #5, gainesville FL investigate the pharmacokinetics (PK) of three generic steroid-based dry powder inhaler (DPI)… HHSF22301005T Food and Drug Administration $7,265
Clinical site monitoring HHSF22301001T Food and Drug Administration $45,090
Show all 29

Transactions

Action Obligated Date
Other Administrative Action P00007 $0
Exercise an Option P00006 $0
Exercise an Option P00005 $0
Exercise an Option P00004 $0
Vendor DUNS or Name Change - Non-Novation P00003 $0
Other Administrative Action 2 $0
Exercise an Option 1 $0
Original award $0

Quick answers

Who was awarded contract HHSF223201710031I?

HHSF223201710031I was awarded to The Emmes Company, LLC by Food and Drug Administration (Department of Health and Human Services) on September 28, 2017.

How much is contract HHSF223201710031I worth?

Orders under HHSF223201710031I have obligated $434,107. Their combined potential value, with all options, is $441,224. HHSF223201710031I's own ceiling is $1,000,000. A single order can be worth up to $1,000,000.

How many orders have been placed under contract HHSF223201710031I?

29 orders have been placed under HHSF223201710031I, the latest on August 9, 2022.

Who can order from contract HHSF223201710031I?

HHSF223201710031I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSF223201710031I competed?

The extent of competition for HHSF223201710031I was competed under sap. The government received 5 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login